The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world’s first and only medical device that can monitor and respond to brain activity.
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company’s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
|HQ||Mountain View, US||Map|
|Employees (est.) (Mar 2019)||142||(+2%)|
NeuroPace total Funding
NeuroPace latest funding size
Time since last funding
|a year ago|
|InterWest Partners, KCK, Kleiner Perkins Caufield & Byers, OrbiMed, New Enterprise Associates, Johnson & Johnson Development Corporation, MedVenture Associates|
NeuroPace has 640 Twitter Followers. The number of followers has increased 2.6% month over month and increased 11% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was NeuroPace founded?
NeuroPace was founded in 1999.
Who are NeuroPace key executives?
NeuroPace's key executives are Frank Fischer, Rebecca Kuhn and Martha Morrell.
How many employees does NeuroPace have?
NeuroPace has 142 employees.
Who are NeuroPace competitors?
Competitors of NeuroPace include DiaMedica Therapeutics, Intersect ENT and Sensome.
Where is NeuroPace headquarters?
NeuroPace headquarters is located at 455 N Bernardo Ave, Mountain View.
Where are NeuroPace offices?
NeuroPace has an office in Mountain View.
How many offices does NeuroPace have?
NeuroPace has 1 office.